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Abstract The conformational preferences of AnxIN26, a peptide
corresponding to residues 2^26 of human annexin I, were
investigated using CD and NMR spectroscopy. CD results
showed that AnxIN26 adopts a mainly K-helical conformation in
membrane-mimetic environments, TFE/water and SDS micelles,
while a predominantly random structure with slight helical
propensity in aqueous buffer. The helical region of AnxIN26
showed a nearly identical conformation between in TFE/water
and in SDS micelles, except for the orientation of the Trp-12
side-chain, which was quite different between the two. The N-
terminal region of the AnxIN26 helix showed a typical amphi-
pathic nature, which could be stabilized by the neighboring
hydrophobic cluster. The helical stability of the peptide in SDS
micelles was increased by addition of calcium ions. These results
suggest that the N-terminal tail domain of human annexin I
interacts with biological membranes in a partially calcium-
dependent manner. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Annexins are a family of ubiquitous proteins that bind to
negatively charged phospholipids in a calcium-dependent
manner, and are known to be involved in many important
cellular processes such as anti-in£ammation, anti-coagulation,
membrane tra⁄cking, etc. [1,2]. Each annexin is composed of
two parts, a major C-terminal core domain and a minor N-
terminal tail domain. The similar properties of all annexins
regarding Ca2 and phospholipid seem to be due to the C-
terminal core domains that show highly conserved sequences
and structures. Since the N-terminal tail domains of annexins
di¡er widely in length and sequence, it has been proposed that
the structurally distinct N-terminal domain of each annexin
may impart functional speci¢city [3^7]. Indeed, there have
been many experimental reports on the di¡erent functional
roles of the N-terminal tail domains of annexins [4^9].
Although the 3D structures of more than 10 annexins are
presently available [8^17], our knowledge of the N-terminal
domain structure of annexins is very scant because these N-
terminal domains are either truncated, as in the case of an-
nexin I, or naturally short. Particularly, no structural evidence
has been reported for whether the N-terminal tail of annexin I
itself binds to membrane, although many reports have noted
that the N-terminal region of annexin I regulates its mem-
brane interaction properties [18^22].
The N-terminal tail domain of annexin I consists of 41
amino acids. However, annexin I lacking residues 1^26 fre-
quently exists in vivo [23]. It is known that the residue Lys-26
is prone to tryptic digestion, and the membrane binding of the
annexin I core domain is regulated by the truncation of the
tail domain at this position [20^22]. These facts suggest that
residues 1^26 of annexin I could interact with the membrane.
In addition, annexin I has a unique tryptophan at position 12
in the N-terminal tail domain. Tryptophan residues are fre-
quently found at the lipid bilayer interface in membrane pro-
teins, where they may be involved in stabilizing correct pro-
tein^membrane interactions [1,24,25]. In particular, the
unique tryptophan of annexin V plays a crucial role in its
membrane binding [26,27].
In this paper, we report the conformational preferences of
the partial N-terminal domain of annexin I at membrane-
mimetic environments by using a peptide corresponding to
residues 2^26 of human annexin I (AnxIN26). The results of
the present report provide structural evidence for the mem-
brane-binding properties of AnxIN26, including the role of the
hydrophobic cluster containing the unique tryptophan of an-
nexin I. Additionally, the e¡ect of Ca2 on the membrane-
binding property of the peptide is investigated.
2. Materials and methods
2.1. Materials and peptide preparation
The synthetic peptide N-acetyl-AMVSEFLKQAWFIENEE-
QEYVQTVK-COOH, corresponding to residues 2^26 of human an-
nexin I, was purchased from Chiron, Australia. The sequence and
purity of the peptide were con¢rmed by mass-spectroscopy and high
performance liquid chromatography. 2,2,2-tri£uoroethanol-d3 99.5%
(TFE-d3) and sodium 4,4-dimethyl-4-silapentane-1-sulfonate (sodium
dodecyl sulfate (SDS)-d25) were obtained from Aldrich. D2O 99.95%
was obtained from Sigma, and all other chemicals were analytical
grade obtained from various manufacturers.
2.2. Circular dichroism (CD) spectroscopy
CD spectra were obtained at 20‡C on a JASCO J-715 spectropo-
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larimeter, using a 1 mm path-length cell, with a 1 nm bandwidth, 0.5
nm step resolution, 4 s response time, and a scan speed of 20 nm
min31. Four scans were added and averaged, followed by subtraction
of the CD signal of the solvent. Samples were prepared by dissolving
the peptide to the concentration of 0.1 mg ml31 in various solvents:
50 mM potassium phosphate bu¡er (pH 6.5), TFE/water mixtures,
and 10 mM SDS. Calcium ions were added by a stock solution of
150 mM CaCl2.
2.3. Nuclear magnetic resonance (NMR) spectroscopy
Samples for NMR measurements contained 3 mM peptide in TFE-
d3/H2O (1:1, v/v) at pH 4.0, and in 300 mM SDS-d25 at pH 4.0. All
NMR spectra were recorded at 40‡C by using a Bruker DRX-500
spectrometer equipped with a gradient unit. The WATERGATE se-
quence [28] was used to suppress the solvent signals in the nuclear
Overhauser e¡ect spectroscopy (NOESY) and total correlation spec-
troscopy (TOCSY) experiments. For the double quantum-¢ltered cor-
relation spectroscopy (DQF-COSY) experiments, solvent suppression
was achieved using selective low-power irradiation of the water reso-
nance. The 2D TOCSY spectra were acquired with isotropic mixing
times of 40 and 60 ms, respectively. The 2D NOESY spectra were
acquired with mixing times of 200 and 300 ms, respectively. Slowly
exchanging amide protons were monitored with a series of 2D NO-
ESY spectra recorded at 5, 50, 140, 230, 320, 410 and 500 min on
AnxIN26 solutions in TFE-d3/D2O (1:1) and in 300 mM SDS-d25/D2O,
respectively. All NMR spectra were processed and analyzed using the
NMRPipe/NMRDraw software and the NMRView program [29,30].
Chemical shifts were referenced to methyl signals of sodium 4,4-di-
methyl-4-silapentane-1-sulfonate.
2.4. Structure calculation
Distance restraints were obtained from the NOESY spectra. NOE
data from the NOESY spectra were classi¢ed into three classes;
strong, medium, and weak, corresponding to upper bound interproton
distance restraints of 3.0, 4.0, and 5.0 Aî , respectively. Lower distance
bounds were taken as the sum of the van der Waals radii of 1.8 Aî .
Pseudoatom corrections were applied to non-speci¢cally assigned
methylene, methyl, and aromatic ring protons [31]. Hydrogen bond
restraints were determined on the basis of slowly exchanging amide
protons and the pattern of the NOEs characteristic of an K-helix. The
3D structures were calculated using the simulated annealing and en-
ergy minimization protocol in the program XPLOR 3.851 [32].
3. Results and discussion
3.1. Conformational preferences of AnxIN26
The conformational preferences of AnxIN26 at di¡erent sol-
vent environments were investigated by CD spectroscopy (Fig.
1). In aqueous bu¡er, the CD spectrum of AnxIN26 showed a
strong negative band at 200 nm and a broad band around 222
nm, indicating a predominantly random-coil conformation
with a slight helical propensity [33,34]. However, in TFE/
water mixtures, the CD spectra showed double minima at
208 and 222 nm, an isodichroic point at 200 nm, and a pos-
itive band at 193 nm, which are indicative of a highly K-helical
conformation [35^37]. The signals at 193, 208, and 222 nm
were intensi¢ed with increasing concentrations of TFE, which
Table 1
1H chemical shifts of AnxIN26 in 50% TFE and in 300 mM SDS micelles, at pH 4.0 and 40‡C
50% TFE Others 300 mM SDS Others
HN HK HL HN HK HL
A2 8.04 4.24 1.48 8.30 4.20 1.48
M3 8.21 4.44 2.14 n.d.a 8.42 4.39 2.12/2.24 HQ 2.68/2.56
V4 7.56 3.92 2.23 HQ 1.07/1.10 7.80 3.83 2.27 HQ 1.10/1.04
S5 7.92 4.22 4.03 8.07 4.11 3.99
E6 7.86 4.23 2.24 HQ 2.55 7.84 4.15 2.21/2.14 HQ 2.50
F7 8.00 4.43 3.32 HN=O 7.28/7.26 7.99 4.40 3.26 HN=O=j 7.24/7.22/7.26
L8 8.27 4.09 1.92 HQ 1.51, HN 1.07/0.97 8.21 4.00 1.99/1.94 HQ 1.52, N 0.95
K9 7.86 4.15 2.02 HQ 1.73/1.53, HN 1.50 7.92 4.09 1.95 HQ=N 1.52/1.70
Q10 7.95 4.28 2.35/2.18 HQ 2.59/2.46, HO 6.69/5.33 7.80 4.40 2.16 HQ 2.50
A11 8.30 4.09 1.44 8.14 4.04 1.30
W12 8.38 4.34 3.45/3.54 HN=O=j 7.17/7.54/7.56 8.25 4.39 3.40 HN=O=j 7.24/7.50/7.51
F13 8.30 4.08 3.38 HN=O 7.35/7.34 7.70 4.12 3.14/3.06 HN 7.17/7.16
I14 8.40 3.70 2.05 HQ1 1.94/1.33, HQ2 0.97, HN 0.94 7.84 3.71 2.01 HQ1 1.71/1.29, HQ2 0.90
E15 8.45 4.12 2.28 HQ 2.61/2.47 8.23 3.96 2.14/2.03 HQ 2.45
N16 8.21 4.03 2.08 HN 7.13/6.49 8.05 4.28 2.46 HN 7.09/6.03
E17 8.21 4.44 2.14 HQ 2.57/2.67 7.91 4.14 2.05 HQ 2.50
E18 8.03 4.10 2.20 HQ 2.45/2.55 8.26 4.18 2.04 HQ 2.35/2.50
Q19 8.45 4.06 2.20 HQ 2.71 8.06 4.03 2.11 HQ 2.45
E20 7.98 4.12 2.20 HQ 2.56 7.91 4.14 2.03 HQ 2.50
Y21 8.21 4.29 3.27/3.19 HN=O 7.12/6.80 7.98 4.39 3.15/3.03 HN=O 7.10/6.79
V22 8.23 3.76 2.26 HQ 1.06/1.18 8.12 3.84 2.22 HQ 1.08/1.00
Q23 7.87 4.23 n.d. n.d. 7.91 4.26 2.10/2.17 HQ 2.43, HO 7.37/6.72
T24 7.79 4.30 4.30 HQ 1.29 7.77 4.31 4.26 HQ 1.25
V25 7.76 4.07 2.03 HQ 0.85/0.89 7.70 4.12 2.09 HQ 0.92
K26 7.88 4.37 1.91 HQ=N=O 1.49/1.72/3.04 7.81 4.29 n.d. HQ 1.46
an.d., not detected.
Fig. 1. CD spectra of AnxIN26 in 50 mM potassium phosphate bu¡-
er (a), in 30% TFE/water mixture (E), in 50% TFE/water mixture
(F), and in 10 mM SDS (b).
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indicates that the helicity of the peptide increased at more
hydrophobic environments. The CD spectrum of AnxIN26 in
10 mM SDS, which is above the critical micellar concentra-
tion of SDS [38], also showed a typical K-helix pattern. This
conformational behavior of AnxIN26 is common to many
membrane-binding peptides [33^37,39^41]. Thus, it can be
suggested that the conformational transition of AnxIN26,
from random-coil in aqueous bu¡er to K-helix in mem-
brane-mimetic environments, re£ects its binding to the mem-
brane.
3.2. NMR structures of AnxIN26
The helical structures of AnxIN26 in TFE/water and in SDS
micelles were precisely investigated by NMR spectroscopy.
Sequence-speci¢c assignments of the proton resonances were
achieved by spin system identi¢cation from TOCSY and
DQF-COSY spectra, followed by sequential assignments
through NOE connectivities [31]. Table 1 lists the nearly com-
plete assignments of the proton chemical shifts of AnxIN26 in
50% TFE/water and in 300 mM SDS micelles. As shown in
Fig. 2, the presence of a typical K-helix from V4 to Q19 is
supported, both in TFE/water and in SDS micelles, by the
frequent observations of dNN(i,i+1), dNN(i,i+2), dKL(i,i+3),
dKN(i,i+3) and dKN(i,i+4) NOE connectivities, and slowly ex-
changing amide protons. A set of 50 structures of AnxIN26 in
50% TFE/water was calculated by using 268 distance re-
straints (105 intraresidue, 98 sequential, and 65 medium range
restraints) and 28 hydrogen bond restraints. Out of the 50
structures, 49 structures without distance violation larger
than 0.5 Aî were accepted, and 20 structures with the lowest
energies ¢nally selected through several rounds of re¢nements.
In the same manner, the ¢nal 20 structures of AnxIN26 in SDS
micelles were selected by using 240 distance restraints (80
intraresidue, 94 sequential, and 66 medium range restraints)
and 26 hydrogen bond restraints. The structural statistics for
the 20 ¢nal structures of AnxIN26 in TFE/water and in SDS
micelles are summarized in Table 2. Fig. 3 shows superimpo-
sitions of the backbone atoms of the ¢nally selected AnxIN26
structures in TFE/water and in SDS micelles, respectively. The
overall structure of AnxIN26 in SDS micelles is similar to that
in TFE/water, and particularly the conformation of the helical
part (V4-Q19) is nearly identical. The relatively disordered
conformation in the C-terminal region of AnxIN26 may be
attributed, both in TFE/water and in SDS micelles, to the
break of the peptide bond between AnxIN26 and the core of
annexin I.
3.3. Structural characteristics for membrane binding
The insight into the spatial structure of AnxIN26 shows
three structural advantages of the peptide for binding to mem-
brane. To begin with, the N-terminal part (V4-W12) of the
AnxIN26 helix (V4-Q19) shows a typical amphipathic charac-
ter, which is depicted in Fig. 4A. In many cases, the amphi-
pathic nature of a helical peptide is known to be important
for membrane binding [33^36,39]. It seems that the non-polar
side chains that extend from the hydrophobic face of AnxIN26
could interact with the hydrophobic acyl chains of micelles, as
proposed for other amphipathic peptides [36].
Fig. 2. Overview of the NOE connectivities and amide proton ex-
change rates of AnxIN26 in TFE/water mixture (A) and in SDS mi-
celles (B). Moderately and slowly exchanging amide protons are rep-
resented as gray circles and ¢lled circles, respectively.
Table 2
Structural statistics for the 20 converged structures of AnxIN26 in 50% TFE and in 300 mM SDS
Statistics for structure calculations 50% TFE 300 mM SDS
R.m.s.d. from idealized covalent geometry
Bonds (Aî ) 0.0024 þ 0.0001 0.0011 þ 0.0001
Bond angles (‡) 0.462 þ 0.006 0.441 þ 0.006
Improper torsion (‡) 0.333 þ 0.006 0.315 þ 0.005
R.m.s.d. from experimental restraints
Distances (Aî ) 0.021 þ 0.002 0.006 þ 0.004
Final energies (kcal mol31)
Etotal 39.2 þ 1.8 27.7 þ 1.3
Ebond 2.4 þ 0.2 0.5 þ 0.1
Eangles 24.8 þ 0.6 22.6 þ 0.6
Eimproper 3.8 þ 0.6 3.4 þ 0.1
EvdW 3.0 þ 0.6 0.7 þ 0.5
ENOE 5.1 þ 0.9 0.5 þ 0.5
Average r.m.s.d. to the mean structure for all atoms/the backbone (Aî )
Whole (2^26) 4.16/2.71 3.10/2.04
Helix (4^19) 1.07/0.30 1.27/0.42
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Second, the hydrophobic cluster ranging from A11 to I14
(-A-W-F-I-) can stabilize the neighboring amphipathic part
and play a key role in membrane binding. As shown in
Fig. 4B, the aromatic rings of W12 and F13 of the re¢ned
average structure of AnxIN26 are oriented more or less per-
pendicular to each other, which is probably due to a favorable
interaction between the two rings [42]. Such aromatic^aro-
matic interactions have been found to stabilize protein struc-
tures, and particularly a hydrophobic cluster including the
WF pair is important for the stabilization of the N-terminal
amphipathic helix of human apolipoprotein E [42,43].
Finally, the residue W12, which is the unique tryptophan
residue of annexin I, seems to be crucial for the membrane
interaction of AnxIN26. When the helical part (V4-Q19, 269
atoms) of the re¢ned average structure of AnxIN26 in SDS
micelles was overlaid with that in TFE/water, the two struc-
tures were matched well with the root mean square deviation
(r.m.s.d.) value of 0.22 Aî for the backbone (Fig. 4B). How-
ever, the orientation of the W12 side chain was remarkably
di¡erent between the two. Since the SDS micelle is heteroge-
neous, it is a more membrane-mimetic environment than
TFE. Thus, the di¡erent orientation of the W12 side chain
seems to re£ect the anchoring role of the residue in the mem-
brane-binding process of AnxIN26, as in the cases of other
membrane-binding proteins [24^27].
3.4. E¡ect of calcium on AnxIN26
It has been proposed that calcium binding may alter the
conformation of the N-terminal region of annexin I, and re-
ciprocally, that alterations in its N-terminal region can modify
its calcium-binding properties [6,19^20]. Thus, we investigated
the calcium-binding ability of AnxIN26 in SDS micelles by CD
spectroscopy (Fig. 5). By an addition of calcium, the CD
signals of AnxIN26 in SDS micelles were intensi¢ed at 193,
208, and 222 nm, which indicates that the helical structure
of the peptide was more stabilized. No further spectral change
was observed with above 5 equimolar calcium, which indicates
a saturation. The calcium-dependent peripheral binding of
annexins to membrane is generally assumed to function via
a ‘Ca2-bridge’, in which the Ca2-ion is coordinated by polar
headgroups of the phospholipid molecules and by ligands
from the proteins [18,44^45]. In annexins, the acidic side-
chains of glutamate residues often contribute to the formation
of a Ca2-binding site [1,45]. The C-terminal region of the
AnxIN26 helix contains frequent glutamate residues (-E15-N-
E-E-Q-E20-; Fig. 4A). Thus, we suggest that Ca2-ions bind
to the negatively charged glutamate-rich region of AnxIN26
and function as salt-bridges between the peptide and SDS
micelle molecules. The calcium-bridge in this region seems
to stabilize the helical conformation of AnxIN26 as a mem-
brane-bound form, resulting in the intensi¢cation of CD sig-
nals as shown in Fig. 5.
3.5. Concluding remarks
This report constitutes the ¢rst detailed structural data of
the N-terminal tail domain of annexin I. Since we studied its
corresponding peptide, the structure of the N-terminal tail
domain of annexin I in its intact form is not clear yet. How-
ever, present results indicate that the annexin I N-terminal tail
Fig. 3. Superimposition of the backbone atoms (N, CK, and CP) of
20 structures in TFE/water mixture (A) and in SDS micelles (B).
Residues 4^19 of AnxIN26 were overlapped with the average r.m.s.d.
values of 0.30 and 0.42 Aî for the backbone, respectively.
Fig. 4. A: Re¢ned average structure of AnxIN26 in SDS micelles. Residues 4^19 are showed as a conic presentation. Hydrophobic and hydro-
philic residues are colored dark and light gray, respectively. B: Superposition of the re¢ned average structures of AnxIN26 in TFE/water (dark)
and in SDS micelles (light). Backbone of residues 4^19 and side chains of the W12 and F13 residues are showed as a neon presentation. The
direction of view is perpendicular (A) and parallel (B) to the helical axis, respectively.
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itself probably binds to membrane even in the absence of
calcium, forming a stable amphipathic helix. In addition, its
membrane-bound state seems to be partially a¡ected by cal-
cium binding. A similar conformational behavior has been
proposed for the annexin II N-terminal tail, for which the
amphipathic K-helical conformation is probably induced by
its protein^protein interaction with p11 [7]. The N-terminal
tail of annexin I, at least the ¢rst 12 amino acids, has been
also proposed to interact with other proteins [4,5]. Particu-
larly, it was con¢rmed recently that not only annexin I but
also its N-terminal peptide, which corresponds to AnxIN26,
has antiin£ammatory e¡ects by serving as a ligand for the
formyl peptide receptor on human neutrophils [5]. Accord-
ingly, the structure formation of the N-terminal domain of
annexin I in the state of protein^protein contact with other
proteins as well as the core of the protein itself might also be
induced and would be worthy of investigation.
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Fig. 5. CD spectra of AnxIN26 in the absence of calcium (a), in the
presence of three equimolar calcium (E), and in the presence of
5 equimolar calcium (F). All of the spectra were obtained with
0.1 mg ml31 of the peptide in 10 mM SDS micelles at 20‡C. The
region from 205 to 230 nm is enlarged in the inset.
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